Medtronic Names Kiil Head of Cardiovascular Business as Salmon Departs

Published: 2025-05-21 07:39:08 ET MDT

Published on 05/21/2025 at 07:39

By Colin Kellaher

The top executive of Medtronic's cardiovascular portfolio, Sean Salmon, is leaving the medical-technology company.

Medtronic on Wednesday said Skip Kiil, previously senior vice president and president of its cranial and spinal-technologies business, has replaced Salmon as executive vice president and president of the cardiovascular portfolio, which accounted for roughly 37% of the company's $33.5 billion in revenue for its latest fiscal year.

Medtronic said Salmon, who joined the company in 2004 and has been at the helm of the cardiovascular portfolio since the start of 2021, is entitled to severance payments and benefits and will remain an employee until Sept. 2.

The company said Michael Carter, vice president and general manager of its spine business, succeeds Kiil as senior vice president and president of the cranial and spinal-technologies business.

Write to Colin Kellaher at [email protected]

(END) Dow Jones Newswires

05-21-25 0738ET